What ’s Next For Moderna Post-Covid-19: CEO Stéphane Bancel Details mRNA Pipeline
One of the world ’s first mRNA vaccines made Bancel a billionaire—and now the biotech CEO discusses his plans to use the mRNA breakthrough for cancer, genetic disorders, and even a better flu vaccine.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Leah Rosenbaum, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Business /business Editors' Pick editors-pick Coronavirus Daily Cover daily-cover Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Coronavirus | COVID-19 | Genetics | Pharmaceuticals | Science | Vaccines